Ann Fehr

Ann Fehr is a declared insider of Aequus Pharmaceuticals Inc., with filings sourced from SEDI. Over a trading history stretching from 22 July 2016 to 7 September 2022, the count stands at 6 filings.

Every open-market trade on record is a purchase: 2 purchases worth €2,967, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 option exercise. In 2022 alone, the filings show 2 purchases and no sales.

The latest filing, published on 7 September 2022, reports an open-market purchase of €461 in Aequus Pharmaceuticals Inc. Typically, a trade is published a median of 5 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.